** Shares of medical equipment maker Thermo Fisher TMO.N rise 1.2% to $574.94 premarket
** Co beats Q4 profit and revenue estimates on improved demand for its products and services used in developing therapies
** Posts Q4 adj. profit of $6.10 per share, beating estimates of $5.94, as per data compiled by LSEG
** Reports Q4 rev of $11.40 billion, ahead of estimates of $11.28 billion
** Co says will provide 2025 forecast on earnings call
** Stock had fallen 2% in 2024
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.